Rishi Sharma

Molecules to market: A probabilistic artificial intelligence framework for predicting managed care adoption at the level of drug discovery.

A 4-layer framework can give MCOs earlier visibility into a therapy's likely clinical profile, cost-effectiveness distribution, and formulary placement probability before a manufacturer's dossier arrives, and allows budget forecasting and contracting strategy to keep pace with growing AI-accelerated pipelines.